Ready to ask questions or get a product demo?

Navigating the New Age of Type 2 Diabetes and Obesity Management

The mounting popularity of GLP-1 therapies is changing how people—and the healthcare system—address type 2 diabetes and obesity care. We'll explore the opportunities and risks of these therapies and examine the role of these medications in the long-term management of two of the costliest conditions organizations face.

Fill out this form to get access.

Meet your speakers

robert gabbay

Dr. Robert Gabbay

Chief Scientific and Medical Officer

American Diabetes Association

Tejaswi Kompala

Dr. Tejaswi Kompala

Clinical Strategy Director for Cardiometabolic Health

Teladoc Health

Related Insights